MGRC unaware of any reason for sharp fall in share price

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC) is not aware of any corporate development or other reasons for the sharp fall in its share price recently.

The genomics firm, which provides healthcare services such as genetic screening and cancer-related immunotherapy, said its board has made due enquiry on the matter with the company’s directors, major shareholders and such other relevant persons.

In its reply to Bursa Malaysia Securities’ unusual market activity query, MGRC said it however remains unaware of any corporate development, including those at the stage of negotiation or discussion, as well as any rumour, report or other possible explanations for the trading activity.

"Further, the board of directors wishes to confirm that the company is in compliance with Bursa Securities Listing Requirement, in particular Paragraph 9.03 of the LR on immediate disclosure obligations,” it added.

Its shares fell 50 sen to RM1.17 at midday break. - Bernama

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

CPO futures likely to undergo technical correction next week
Econpile issues termination notice to Gabungan Strategik
Intel's US$20bil Ohio factory could become world's largest chip plant
Shrunken US oil inventories point to chronic under-supply
Royal Dutch no more - Shell officially changes name
Oil price slides, but climbs for 5th week on supply concerns
GLOBAL MARKETS-Bond yields tumble as Netflix fuels stock market sell-off
Rising interest rate fallout unlikely
Policy normalisation can lend support to ringgit
Short Position - Green bond, O&G funding, Going the EV way

Others Also Read